Global mRNA Vaccines & Therapeutics Market Insights and Forecast to 2027

    • ID: AR3088974
    • 20 June, 2021
    • Other
    • Region: Global
    • 118 Pages
    • QYResearch

    1 Study Coverage

    • 1.1 mRNA Vaccines & Therapeutics Product Introduction
    • 1.2 Market by Type
      • 1.2.1 Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Type
      • 1.4.2 Infectious Disease Vaccines
      • 1.4.3 Cancer Vaccines
    • 1.3 Market by Application
      • 1.3.1 Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Application
      • 1.3.2 Standardized Preselected
      • 1.3.3 Prophylactic Vaccines
      • 1.3.4 Individualized Shared Antigens
      • 1.3.5 Synthetic Self-Amplifying Mrna Vaccines for Pandemic Outbreaks
      • 1.3.6 Therapeutic Vaccines
      • 1.3.7 Individualized Neoantigens
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Executive Summary

    • 2.1 Global mRNA Vaccines & Therapeutics Sales Estimates and Forecasts 2016-2027
    • 2.2 Global mRNA Vaccines & Therapeutics Revenue Estimates and Forecasts 2016-2027
    • 2.3 Global mRNA Vaccines & Therapeutics Revenue by Region: 2016 VS 2021 VS 2027
    • 2.4 Global Top mRNA Vaccines & Therapeutics Regions by Sales
      • 2.4.1 Global Top mRNA Vaccines & Therapeutics Regions by Sales (2016-2021)
      • 2.4.2 Global Top mRNA Vaccines & Therapeutics Regions by Sales (2022-2027)
    • 2.5 Global Top mRNA Vaccines & Therapeutics Regions by Revenue
      • 2.5.1 Global Top mRNA Vaccines & Therapeutics Regions by Revenue (2016-2021)
      • 2.5.2 Global Top mRNA Vaccines & Therapeutics Regions by Revenue (2022-2027)
    • 2.6 North America
    • 2.7 Europe
    • 2.8 Asia-Pacific
    • 2.9 Latin America
    • 2.10 Middle East & Africa

    3 Competition by Manufacturers

    • 3.1 Global mRNA Vaccines & Therapeutics Sales by Manufacturers
      • 3.1.1 Global Top mRNA Vaccines & Therapeutics Manufacturers by Sales (2016-2021)
      • 3.1.2 Global Top mRNA Vaccines & Therapeutics Manufacturers Market Share by Sales (2016-2021)
      • 3.1.3 Global Top 10 and Top 5 Companies by mRNA Vaccines & Therapeutics Sales in 2020
    • 3.2 Global mRNA Vaccines & Therapeutics Revenue by Manufacturers
      • 3.2.1 Global Top mRNA Vaccines & Therapeutics Manufacturers by Revenue (2016-2021)
      • 3.2.2 Global Top mRNA Vaccines & Therapeutics Manufacturers Market Share by Revenue (2016-2021)
      • 3.2.3 Global Top 10 and Top 5 Companies by mRNA Vaccines & Therapeutics Revenue in 2020
    • 3.3 Global mRNA Vaccines & Therapeutics Sales Price by Manufacturers
    • 3.4 Analysis of Competitive Landscape
      • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      • 3.4.3 Global mRNA Vaccines & Therapeutics Manufacturers Geographical Distribution
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Global mRNA Vaccines & Therapeutics Sales by Type
      • 4.1.1 Global mRNA Vaccines & Therapeutics Historical Sales by Type (2016-2021)
      • 4.1.2 Global mRNA Vaccines & Therapeutics Forecasted Sales by Type (2022-2027)
      • 4.1.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2027)
    • 4.2 Global mRNA Vaccines & Therapeutics Revenue by Type
      • 4.2.1 Global mRNA Vaccines & Therapeutics Historical Revenue by Type (2016-2021)
      • 4.2.2 Global mRNA Vaccines & Therapeutics Forecasted Revenue by Type (2022-2027)
      • 4.2.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2016-2027)
    • 4.3 Global mRNA Vaccines & Therapeutics Price by Type
      • 4.3.1 Global mRNA Vaccines & Therapeutics Price by Type (2016-2021)
      • 4.3.2 Global mRNA Vaccines & Therapeutics Price Forecast by Type (2022-2027)

    5 Market Size by Application

    • 5.1 Global mRNA Vaccines & Therapeutics Sales by Application
      • 5.1.1 Global mRNA Vaccines & Therapeutics Historical Sales by Application (2016-2021)
      • 5.1.2 Global mRNA Vaccines & Therapeutics Forecasted Sales by Application (2022-2027)
      • 5.1.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2027)
    • 5.2 Global mRNA Vaccines & Therapeutics Revenue by Application
      • 5.2.1 Global mRNA Vaccines & Therapeutics Historical Revenue by Application (2016-2021)
      • 5.2.2 Global mRNA Vaccines & Therapeutics Forecasted Revenue by Application (2022-2027)
      • 5.2.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2016-2027)
    • 5.3 Global mRNA Vaccines & Therapeutics Price by Application
      • 5.3.1 Global mRNA Vaccines & Therapeutics Price by Application (2016-2021)
      • 5.3.2 Global mRNA Vaccines & Therapeutics Price Forecast by Application (2022-2027)

    6 North America

    • 6.1 North America mRNA Vaccines & Therapeutics Market Size by Type
      • 6.1.1 North America mRNA Vaccines & Therapeutics Sales by Type (2016-2027)
      • 6.1.2 North America mRNA Vaccines & Therapeutics Revenue by Type (2016-2027)
    • 6.2 North America mRNA Vaccines & Therapeutics Market Size by Application
      • 6.2.1 North America mRNA Vaccines & Therapeutics Sales by Application (2016-2027)
      • 6.2.2 North America mRNA Vaccines & Therapeutics Revenue by Application (2016-2027)
    • 6.3 North America mRNA Vaccines & Therapeutics Market Size by Country
      • 6.3.1 North America mRNA Vaccines & Therapeutics Sales by Country (2016-2027)
      • 6.3.2 North America mRNA Vaccines & Therapeutics Revenue by Country (2016-2027)
      • 6.3.3 U.S.
      • 6.3.4 Canada

    7 Europe

    • 7.1 Europe mRNA Vaccines & Therapeutics Market Size by Type
      • 7.1.1 Europe mRNA Vaccines & Therapeutics Sales by Type (2017-2027)
      • 7.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Type (2017-2027)
    • 7.2 Europe mRNA Vaccines & Therapeutics Market Size by Application
      • 7.2.1 Europe mRNA Vaccines & Therapeutics Sales by Application (2017-2027)
      • 7.2.2 Europe mRNA Vaccines & Therapeutics Revenue by Application (2017-2027)
    • 7.3 Europe mRNA Vaccines & Therapeutics Market Size by Country
      • 7.3.1 Europe mRNA Vaccines & Therapeutics Sales by Country (2017-2027)
      • 7.3.2 Europe mRNA Vaccines & Therapeutics Revenue by Country (2017-2027)
      • 7.3.3 Germany
      • 7.3.4 France
      • 7.3.5 U.K.
      • 7.3.6 Italy
      • 7.3.7 Russia

    8 Asia Pacific

    • 8.1 Asia Pacific mRNA Vaccines & Therapeutics Market Size by Type
      • 8.1.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Type (2018-2027)
      • 8.1.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Type (2018-2027)
    • 8.2 Asia Pacific mRNA Vaccines & Therapeutics Market Size by Application
      • 8.2.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Application (2018-2027)
      • 8.2.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Application (2018-2027)
    • 8.3 Asia Pacific mRNA Vaccines & Therapeutics Market Size by Region
      • 8.3.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Region (2018-2027)
      • 8.3.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Region (2018-2027)
      • 8.3.3 China
      • 8.3.4 Japan
      • 8.3.5 South Korea
      • 8.3.6 India
      • 8.3.7 Australia
      • 8.3.8 Taiwan
      • 8.3.9 Indonesia
      • 8.3.10 Thailand
      • 8.3.11 Malaysia

    9 Latin America

    • 9.1 Latin America mRNA Vaccines & Therapeutics Market Size by Type
      • 9.1.1 Latin America mRNA Vaccines & Therapeutics Sales by Type (2019-2027)
      • 9.1.2 Latin America mRNA Vaccines & Therapeutics Revenue by Type (2019-2027)
    • 9.2 Latin America mRNA Vaccines & Therapeutics Market Size by Application
      • 9.2.1 Latin America mRNA Vaccines & Therapeutics Sales by Application (2019-2027)
      • 9.2.2 Latin America mRNA Vaccines & Therapeutics Revenue by Application (2019-2027)
    • 9.3 Latin America mRNA Vaccines & Therapeutics Market Size by Country
      • 9.3.1 Latin America mRNA Vaccines & Therapeutics Sales by Country (2019-2027)
      • 9.3.2 Latin America mRNA Vaccines & Therapeutics Revenue by Country (2019-2027)
      • 9.3.3 Mexico
      • 9.3.4 Brazil
      • 9.3.5 Argentina

    6 Middle East and Africa

    • 6.1 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Type
      • 6.1.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Type (2016-2027)
      • 6.1.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Type (2016-2027)
    • 6.2 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Application
      • 6.2.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Application (2016-2027)
      • 6.2.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Application (2016-2027)
    • 6.3 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Country
      • 6.3.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2016-2027)
      • 6.3.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2016-2027)
      • 6.3.3 Turkey
      • 6.3.4 Saudi Arabia
      • 6.3.5 UAE

    11 Company Profiles

    • 11.1 Moderna Therapeutics
      • 11.1.1 Moderna Therapeutics Corporation Information
      • 11.1.2 Moderna Therapeutics Overview
      • 11.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Description
      • 11.1.5 Moderna Therapeutics Related Developments
    • 11.2 CureVac
      • 11.2.1 CureVac Corporation Information
      • 11.2.2 CureVac Overview
      • 11.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.2.4 CureVac mRNA Vaccines & Therapeutics Product Description
      • 11.2.5 CureVac Related Developments
    • 11.3 Translate Bio
      • 11.3.1 Translate Bio Corporation Information
      • 11.3.2 Translate Bio Overview
      • 11.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.3.4 Translate Bio mRNA Vaccines & Therapeutics Product Description
      • 11.3.5 Translate Bio Related Developments
    • 11.4 BioNTech
      • 11.4.1 BioNTech Corporation Information
      • 11.4.2 BioNTech Overview
      • 11.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.4.4 BioNTech mRNA Vaccines & Therapeutics Product Description
      • 11.4.5 BioNTech Related Developments
    • 11.5 Sangamo Therapeutics
      • 11.5.1 Sangamo Therapeutics Corporation Information
      • 11.5.2 Sangamo Therapeutics Overview
      • 11.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Description
      • 11.5.5 Sangamo Therapeutics Related Developments
    • 11.6 Argos Therapeutics
      • 11.6.1 Argos Therapeutics Corporation Information
      • 11.6.2 Argos Therapeutics Overview
      • 11.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Product Description
      • 11.6.5 Argos Therapeutics Related Developments
    • 11.7 In-Cell-Art
      • 11.7.1 In-Cell-Art Corporation Information
      • 11.7.2 In-Cell-Art Overview
      • 11.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Product Description
      • 11.7.5 In-Cell-Art Related Developments
    • 11.8 eTheRNA
      • 11.8.1 eTheRNA Corporation Information
      • 11.8.2 eTheRNA Overview
      • 11.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.8.4 eTheRNA mRNA Vaccines & Therapeutics Product Description
      • 11.8.5 eTheRNA Related Developments
    • 11.9 Ethris
      • 11.9.1 Ethris Corporation Information
      • 11.9.2 Ethris Overview
      • 11.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.9.4 Ethris mRNA Vaccines & Therapeutics Product Description
      • 11.9.5 Ethris Related Developments
    • 11.10 Tiba Biotechnology
      • 11.10.1 Tiba Biotechnology Corporation Information
      • 11.10.2 Tiba Biotechnology Overview
      • 11.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Description
      • 11.10.5 Tiba Biotechnology Related Developments
    • 11.1 Moderna Therapeutics
      • 11.1.1 Moderna Therapeutics Corporation Information
      • 11.1.2 Moderna Therapeutics Overview
      • 11.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Description
      • 11.1.5 Moderna Therapeutics Related Developments

    12 Value Chain and Sales Channels Analysis

    • 12.1 mRNA Vaccines & Therapeutics Value Chain Analysis
    • 12.2 mRNA Vaccines & Therapeutics Key Raw Materials
      • 12.2.1 Key Raw Materials
      • 12.2.2 Raw Materials Key Suppliers
    • 12.3 mRNA Vaccines & Therapeutics Production Mode & Process
    • 12.4 mRNA Vaccines & Therapeutics Sales and Marketing
      • 12.4.1 mRNA Vaccines & Therapeutics Sales Channels
      • 12.4.2 mRNA Vaccines & Therapeutics Distributors
    • 12.5 mRNA Vaccines & Therapeutics Customers

    13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

    • 13.1 mRNA Vaccines & Therapeutics Industry Trends
    • 13.2 mRNA Vaccines & Therapeutics Market Drivers
    • 13.3 mRNA Vaccines & Therapeutics Market Challenges
    • 13.4 mRNA Vaccines & Therapeutics Market Restraints

    14 Key Findings in The Global mRNA Vaccines & Therapeutics Study

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Author Details

      mRNA Vaccines & Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Vaccines & Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

      Segment by Type
      Infectious Disease Vaccines
      Cancer Vaccines

      Segment by Application
      Standardized Preselected
      Prophylactic Vaccines
      Individualized Shared Antigens
      Synthetic Self-Amplifying Mrna Vaccines for Pandemic Outbreaks
      Therapeutic Vaccines
      Individualized Neoantigens

      By Company
      Moderna Therapeutics
      CureVac
      Translate Bio
      BioNTech
      Sangamo Therapeutics
      Argos Therapeutics
      In-Cell-Art
      eTheRNA
      Ethris
      Tiba Biotechnology

      By Region
      North America
      U.S.
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia



      Summary:
      mRNA Vaccines & Therapeutics Market Research Report is about mRNA Vaccines & Therapeutics Industry study. Get complete mRNA Vaccines & Therapeutics market research report published after Market Study, Industrial Analysis with Trends & Statistics. mRNA Vaccines & Therapeutics Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED